Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis reactive, Erythema, Fatigue, Joint stiffness
Clinical narrative: form of reactive arthritis; Muscle aches that are painful enough to disrupt daily activities; painful enough to disrupt daily activities; muscle stiffness; joint pain and stiffness; joint pain and stiffness; my skin will turn red and be warm to touch; my skin will turn red and be warm to touch; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Jun2021 (Lot number: EW0181) at the age of 30 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic idiopathic hives" (unspecified if ongoing); "PMS" (unspecified if ongoing); "Known allergies: Wheat" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?:Yes. Concomitant medication(s) included: STERILINE; XOLAIR; MIRENA. Past drug history included: Suprax, reaction(s): "known allergies", notes: Known allergies: Suprax. Vaccination history included: Bnt162b2 (lot number: EW0186, vaccine location: Left arm), administration date: 27May2021, when the patient was 29 years old, for covid-19 immunisation. The following information was reported: ARTHRITIS REACTIVE (medically significant) with onset 18Jun2021, outcome "not recovered", described as "form of reactive arthritis"; MYALGIA (non-serious) with onset 18Jun2021, outcome "not recovered", described as "Muscle aches that are painful enough to disrupt daily activities"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 18Jun2021, outcome "not recovered", described as "painful enough to disrupt daily activities"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 18Jun2021, outcome "not recovered", described as "muscle stiffness"; ARTHRALGIA (non-serious), JOINT STIFFNESS (non-serious) all with onset 18Jun2021, outcome "not recovered" and all described as "joint pain and stiffness"; ERYTHEMA (non-serious), SKIN WARM (non-serious) all with onset 18Jun2021, outcome "not recovered" and all described as "my skin will turn red and be warm to touch"; FATIGUE (non-serious) with onset 18Jun2021, outcome "not recovered", described as "fatigue". The events "form of reactive arthritis", "muscle aches that are painful enough to disrupt daily activities", "painful enough to disrupt daily activities", "muscle stiffness", "joint pain and stiffness", "joint pain and stiffness", "my skin will turn red and be warm to touch", "my skin will turn red and be warm to touch" and "fatigue" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive. Therapeutic measures (Prescription NSAID and Flexeril) were taken as a result of arthritis reactive, myalgia, loss of personal independence in daily activities, musculoskeletal stiffness, arthralgia, joint stiffness, erythema, skin warm, fatigue. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.